JP2023512487A5 - - Google Patents

Info

Publication number
JP2023512487A5
JP2023512487A5 JP2022543648A JP2022543648A JP2023512487A5 JP 2023512487 A5 JP2023512487 A5 JP 2023512487A5 JP 2022543648 A JP2022543648 A JP 2022543648A JP 2022543648 A JP2022543648 A JP 2022543648A JP 2023512487 A5 JP2023512487 A5 JP 2023512487A5
Authority
JP
Japan
Prior art keywords
2dehspm
treatment
pharmaceutical product
patient
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022543648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014112 external-priority patent/WO2021150559A1/en
Publication of JP2023512487A publication Critical patent/JP2023512487A/ja
Publication of JP2023512487A5 publication Critical patent/JP2023512487A5/ja
Pending legal-status Critical Current

Links

JP2022543648A 2020-01-20 2021-01-20 癌を治療するための投与養生法および方法 Pending JP2023512487A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062963492P 2020-01-20 2020-01-20
US62/963,492 2020-01-20
PCT/US2021/014112 WO2021150559A1 (en) 2020-01-20 2021-01-20 Dosing regimens and methods for treating cancer

Publications (2)

Publication Number Publication Date
JP2023512487A JP2023512487A (ja) 2023-03-27
JP2023512487A5 true JP2023512487A5 (cg-RX-API-DMAC7.html) 2024-01-24

Family

ID=76992702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022543648A Pending JP2023512487A (ja) 2020-01-20 2021-01-20 癌を治療するための投与養生法および方法

Country Status (6)

Country Link
US (1) US20230064990A1 (cg-RX-API-DMAC7.html)
EP (1) EP4093386A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023512487A (cg-RX-API-DMAC7.html)
AU (1) AU2021210867A1 (cg-RX-API-DMAC7.html)
CA (1) CA3164914A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021150559A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026501282A (ja) * 2022-12-20 2026-01-14 ジェネンテック， インコーポレイテッド Ｐｄ－１軸結合アンタゴニストおよびｒｎａワクチンを用いて膵臓がんを処置する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160022A (en) * 1999-07-19 2000-12-12 University Of Florida Chemical resection of pancreas
US20130137772A1 (en) * 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
WO2017062704A1 (en) * 2015-10-08 2017-04-13 Sun Biopharma, Inc. Compositions and methods for treating pancreatitis
US10195188B2 (en) * 2016-06-13 2019-02-05 Chemocentryx, Inc. Method of treating pancreatic cancer
EP4257581A1 (en) * 2018-01-30 2023-10-11 Panbela Therapeutics, Inc. Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol

Similar Documents

Publication Publication Date Title
JP2020033360A5 (cg-RX-API-DMAC7.html)
JP2022525149A5 (cg-RX-API-DMAC7.html)
JP2022509358A5 (cg-RX-API-DMAC7.html)
JP2025020134A5 (cg-RX-API-DMAC7.html)
JP2011511071A5 (cg-RX-API-DMAC7.html)
RU2020120593A (ru) Способы лечения раннего рака молочной железы трастузумабом-mcc-dm1 и пертузумабом
JP2019533684A5 (cg-RX-API-DMAC7.html)
JP2024518947A5 (cg-RX-API-DMAC7.html)
JP2022509262A5 (cg-RX-API-DMAC7.html)
JP2023501375A5 (cg-RX-API-DMAC7.html)
JP2018526460A5 (cg-RX-API-DMAC7.html)
JP2021509395A5 (cg-RX-API-DMAC7.html)
JP2020536121A5 (cg-RX-API-DMAC7.html)
JP2022531251A5 (cg-RX-API-DMAC7.html)
JP2025148449A5 (cg-RX-API-DMAC7.html)
OA12845A (en) Single dose azithromycin for treating respiratory infections.
JP2022551691A5 (cg-RX-API-DMAC7.html)
JP2019534251A5 (cg-RX-API-DMAC7.html)
JP2023512487A5 (cg-RX-API-DMAC7.html)
JPH09504798A (ja) 早発性射精の治療におけるアルフゾシンまたはテラゾシンの使用
Goldschmidt et al. Compound cardiac toxicity of oral erythromycin and verapamil
JP2022035920A5 (cg-RX-API-DMAC7.html)
JP2022550828A5 (cg-RX-API-DMAC7.html)
RU99119233A (ru) Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени
JP2021512086A5 (cg-RX-API-DMAC7.html)